检索

期
标题
作者
卷 96, 编号 9 (2024): Issues of cardiology
Antihypertensive therapy in patients with arterial hypertension and concomitant diseases in real clinical practice (according to the National Registry of Arterial Hypertension, 2019–2022)
Aksenova A., Oschepkova E., Chazova I.
PDF
(Rus)
卷 94, 编号 5 (2022)
Janus kinase inhibitors in immunoinflammatory rheumatic diseases
Nasonov E.
PDF
(Rus)
卷 92, 编号 9 (2020)
Upper gastrointestinal bleeding in patients with stable coronary artery disease (registry of antithrombotic therapy “REGATТA” results)
Shakhmatova O., Komarov A., Korobkova V., Yarovaya E., Andreevskaya M., Shuleshova A., Panchenko E.
PDF
(Rus)
卷 91, 编号 8 (2019)
New directions of pharmacotherapy of immune - inflammatory rheumatic diseases
Nasonov E.
PDF
(Rus)
卷 90, 编号 8 (2018)
Modern achievements in the diagnosis and treatment of the refractory gastroesophageal reflux disease
Ivashkin V., Maev I., Trukhmanov A., Rumyantseva D.
PDF
(Rus)
卷 86, 编号 12 (2014)
Antiplatelet therapy with acetylsalicylic acid: Approaches to reducing the frequency of gastrointenstinal adverse reactions
Onuchina E.
卷 85, 编号 11 (2013)
Triple therapy for chronic hepatitis C: Practical Aspects
Bakulin I., Kiseleva A.
卷 84, 编号 8 (2012)
Cough: Differential diagnosis and differentiated treatment
Sinopal'nikov A., Kliachkina I.
卷 81, 编号 10 (2009)
Essential hypertension, dementia, and antihypertensive therapy in geriatric patients
Kobalava Z., Kotovskaya Y., Tyul'kina E., Kobalava Z., Kotovskaya Y., Tyulkina E.
卷 80, 编号 12 (2008)
Effects of different treatments on endothelial function in patients with erectile dysfunction and hypogonadism
Mazo E., Gamidov S., Sotnikova E., Mazo E., Gamidov S., Sotnikova E.
卷 79, 编号 6 (2004)
Endothelium a new target for a therapeutic action of ACE inhibitors
Karpov Y.
卷 96, 编号 5 (2024): Issues of rheumatology
Reduction in the need for glucocorticoids on the background of therapy with biologic disease-modifying antirheumatic drugs and Janus kinase inhibitors in rheumatoid arthritis: evidence from real clinical practice
Potapova A., Karateev A., Polishchuk E., Filatova E., Amirdzhanova V., Lila A.
PDF
(Rus)
卷 94, 编号 4 (2022)
SGLT2 inhibitors in acute decompensated heart failure, what do we know?
Lapteva A., Nasonova S., Zhirov I., Tereshchenko S.
PDF
(Rus)
卷 92, 编号 9 (2020)
COVID-19 and cardiovascular diseases
Chazova I., Mironova O.
PDF
(Rus)
卷 91, 编号 5 (2019)
Rheumatoid arthritis: achievements and unresolved issues
Nasonov E., Lila A.
PDF
(Rus)
卷 89, 编号 11 (2017)
Schnitzler syndrome: A review of literature, the authors’ observation, and experience with the interleukin-1 inhibitor canakinumab
Salugina S., Gorodetsky V., Fedorov E., Lopatina N., Evsikova M.
PDF
(Rus)
卷 86, 编号 12 (2014)
Efficacy of a fixed-dose combination of perindopril and amlodipine in the treatment of hypertensive patients. A clinical case
Poteshkina N., Khashieva F.
卷 85, 编号 9 (2013)
Angioprotektivnoe properties lowering drugs from the group of inhibitors of dipeptidyl peptidase-4
Oskola E., Shubina A., Karpov I.
卷 84, 编号 6 (2012)
PHARMACOLOGICAL NEPHROPROTECTION IN CHRONIC KIDNEY DISEASE: CURRENT OPPORTUNITIES AND PERSPECTIVES (REVIEW OF FOREIGN LITERATURE)
Nikolaev A.
卷 81, 编号 8 (2009)
Clinical implications of urine matrix metalloproteinases assay in patients with chronic glomerulonephritis
Li O., Bobkova I., Kozlovskaya L., Lee O., Bobkova I., Kozlovskaya L.
卷 78, 编号 11 (2003)
Impact of long-term antihypertensive therapy on the vasoregulating function of the brachial artery in patients with arterialhypertension associated with type 2 diabetes mellitus
Karpov R., Koshelskaya O., Falkovskaya A., Ocheredko N., Atroshenkov A., Makarova Y.
卷 96, 编号 4 (2024): Issues of diagnostics of internal diseases
Long-term uroseptic and metabolic effects of a herbal medicinal preparation in women with type 2 diabetes taken gliflosins
Tsygankova O., Timoshchenko O., Apartseva N., Latyntseva L.
PDF
(Rus)
卷 93, 编号 9 (2021)
Tactics of antihypertensive therapy during COVID-19 pandemic
Podzolkov V., Bragina A., Rodionova Y., Bragina G., Bykova E.
PDF
(Rus)
卷 92, 编号 7 (2020)
Successful use of long-term follow-up in patients with chronic myeloid leukemia with a deep molecular response at reduced doses of 2nd generation tyrosine kinase inhibitors: clinical cases and literature review
Gurianova M., Chelysheva E., Shukhov O., Turkina A.
PDF
(Rus)
卷 82, 编号 1 (2010)
Chronic gout: causes, clinical manifestations, treatment
Barskova V., Barskova V.
卷 89, 编号 8 (2017)
Molecular genetic predictors of resistance to anti-Helicobacter pylori therapy
Maev I., Andreev D.
PDF
(Rus)
卷 86, 编号 10 (2014)
The problem of viral hepatitis C in the Russian Federation
Iushchuk N., Znoĭko O., Dudina K., Belyĭ P.
卷 85, 编号 9 (2013)
What is the optimal choice of antihypertensive therapy based on: the class-specific effects or special properties of a drug?
Adasheva T., Samorukova E., Zadionchenko V., Nesterenko O.
卷 84, 编号 6 (2012)
CURRENT ANTI-INFLAMMATORY TREATMENT IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Shmelev E., Shmeleva N.
卷 81, 编号 8 (2009)
Renin as a target of direct pharmacological block in arterial hypertension
Mukhin N., Fomin V., Mukhin N., Fomin V.
卷 78, 编号 10 (2003)
Clinical and hemodynamic efficacy ofprestarium and its role in the treatment of chronic pulmonary heart
Korneichuk N., Butorov I., Verbitsky O., Butorova V., Paraska V.
卷 96, 编号 1 (2024): Outpatient care issues and organization of medical care
Pharmacogenetics of dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes mellitus: A review
Samoilova I., Vaizova O., Stankova A., Matveeva M., Podchinenova D., Kudlay D., Borozinets A., Filippova T., Grishkevich I., Partala A., Gerasimova D.
PDF
(Rus)
卷 93, 编号 6 (2021)
Kidney injury associated with antitumor therapy: focus on the adverse events of modern immuno-oncological drugs
Kamyshova E., Bobkova I., Sekacheva M.
PDF
(Rus)
卷 92, 编号 6 (2020)
Modern view on treatment of membranous nephropathy
Bobkova I., Kamyshova E.
PDF
(Rus)
卷 90, 编号 9 (2018)
Proton pump inhibitors receiving and prognosis of patients after scheduled percutaneous coronary interventions
Komarov A., Shakhmatova O., Muraseeva V., Novikova E., Guskova E., Panchenko E.
PDF
(Rus)
卷 89, 编号 2 (2017)
Possibilities for optimization of eradication therapy for Helicobacter pylori infection in modern clinical practice
Andreev D., Dicheva D., Maev I.
PDF
(Rus)
卷 86, 编号 9 (2014)
Principles of choice of an angiotensin-converting enzyme inhibitor: Specific features of perindopril
Morozova T., Gontarenko S., Kuz'mina E.
卷 85, 编号 11 (2013)
Experience with Invirase as part of triple therapy as the drug of choice in the perinatal prevention of HIV transmission in the Ulyanovsk Region
Salminskaia O.
卷 84, 编号 8 (2012)
Role of matrix metalloproteinase-9 in the pathogenesis of osteoporosis in patients with chronic obstructive pulmonary disease
Kochetkova E., Ugaĭ L., Maĭstrovskaia I., Buria K., Nevzorova V.
卷 81, 编号 7 (2009)
Significance of matrix metalloproteinases and their ihhibitors in normal subjects, solid and blood cancer patients
Gaydamaka N., Parovichnikova E., Zavalishina L., Savchenko V., Frank G., Gaidamaka N., Parovichnikova E., Zavalishina L., Savchenko V., Frank G.
卷 80, 编号 2 (2008)
Influence of long-term intake of proton pump inhibitors on gastric mucosa and neuroendocrine system of gastric secretion regulation in patients with acid-dependent diseases
Rapoport S., Khutsishvili M., Rasulov M., Trubitsina I., Raĭkhlin I.
卷 78, 编号 5 (2003)
Interaction of nonsteroid antiinflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)
Tsurko V., Preobrazhensky D., Obukhova О.
51 - 92 的 92 信息 << < 1 2 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语